Cravatex Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 870.96 million compared to INR 1,594.34 million a year ago. Revenue was INR 894.14 million compared to INR 1,615.51 million a year ago. Net income was INR 853.84 million compared to net loss of INR 36.59 million a year ago. Basic earnings per share from continuing operations was INR 330.42 compared to basic loss per share from continuing operations of INR 14.16 a year ago. Diluted earnings per share from continuing operations was INR 330.42 compared to diluted loss per share from continuing operations of INR 14.16 a year ago.
For the nine months, sales was INR 4,199.17 million compared to INR 4,397.19 million a year ago. Revenue was INR 4,262.55 million compared to INR 4,465.06 million a year ago. Net income was INR 550.96 million compared to net loss of INR 207.02 million a year ago. Basic earnings per share from continuing operations was INR 213.21 compared to basic loss per share from continuing operations of INR 80.12 a year ago. Diluted earnings per share from continuing operations was INR 213.21 compared to diluted loss per share from continuing operations of INR 80.12 a year ago.